SCHEMBL6003170

SCHEMBL6003170

COCCCCc1cscc2cccc1-2

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.32
TYMS P04818 1/20 0.32
ADRB2 P07550 1/20 0.31
SCN8A Q9UQD0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29384385 0.75 DPP4 (0.47) KDM4EGAAL3MBTL1ADRB2SCN8A
SCHEMBL2096734 0.69 CYP2A6 (0.33) KDM4EL3MBTL1
SCHEMBL28318473 0.66 ALOX5 (0.53)
SCHEMBL16670387 0.65 ALOX5 (0.51)
SCHEMBL2095475 0.65 GAA (0.38) KDM4EGAA
SCHEMBL15184061 0.64 TSHR (0.39) KDM4E
SCHEMBL12016037 0.64 TAAR1 (0.50) L3MBTL1
SCHEMBL8814675 0.64 TAAR1 (0.50) KDM4E
SCHEMBL792179 0.64 DPP4 (0.50) KDM4EGAAL3MBTL1ADRB2SCN8A
SCHEMBL2094586 0.64 LTA4H (0.44) KDM4EGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed